68Ga‑DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel‑Lindau Syndrome
10.1007/s13139-022-00761-7
- Author:
Mayank PATEL
1
;
Abhishek JHA
;
Tatjana ANTIC
;
Sarah M. NIELSEN
;
Jane E. CHURPEK
;
Alexander LING
;
Karel PACAK
Author Information
1. Section on Medical Neuroendocrinology, Developmental Endocrine Oncology and Genetics Affinity Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., MSC‑1109, Bldg. 10, CRC, Room 1E‑3140, Bethesda, MD 20892‑1109, USA
- Publication Type:INTERESTING IMAGE
- From:Nuclear Medicine and Molecular Imaging
2022;56(5):259-562
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although rare, a metastatic renal cell carcinoma could present with 68Ga-DOTATATE avidity. A 66-year-old man with von Hippel-Lindau syndrome (VHL) presented with 68Ga-DOTATATE uptake in the pancreatic head, splenic hilar region, and multiple osseous sites, including the right lateral portion of the T9 vertebrae. Biopsy of the T9 lesion confirmed metastatic renal cell carcinoma. Various VHL-associated cancers may display 68Ga-DOTATATE avidity, which can change and guide clinical decisions for the patient.
